Literature DB >> 25487197

Enteral stents are safe and effective to relieve malignant gastric outlet obstruction in the elderly.

Hala Mansoor1, Faisal Zeb.   

Abstract

BACKGROUND: Nausea, vomiting and intolerance to oral intake are usually the first presenting symptoms of gastric outlet obstruction, which not only cause malnutrition and increases chances of aspiration pneumonia but also greatly impair the quality of life. Self expandable metallic stents (SEMS) are both effective and safe to relieve the distressing symptoms of gastric outlet obstruction. The aim of this study was to compare the outcomes of endoscopic enteral stent insertion in malignant gastric outlet obstruction in older versus younger patients.
METHODS: Eighty two patients were identified to have undergone SEMs insertion for malignant gastric outlet obstruction. Of these, 26 were ≥65 years (older patient group) and 56 were ≤65 years (younger patient group). These were retrospectively reviewed to assess the success rate and the complications of the procedure.
RESULTS: Both groups were comparable in terms of technical success (100 % in older patient group versus 97 % in younger patient group). Clinical success rate, as determined by gastric outlet obstruction scoring system score (GOOSS) was also similar in both groups. Additionally, the rate of complications in both groups was also comparable, 27 % in older patient versus 23 % in younger patients (p = 0.085).
CONCLUSION: Enteral stenting for malignant gastric outlet obstruction is effective in the older patient groups with its success rate and complications comparable to younger patient population.

Entities:  

Mesh:

Year:  2015        PMID: 25487197     DOI: 10.1007/s12029-014-9675-y

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  25 in total

1.  Quality assurance guidelines for placement of gastroduodenal stents.

Authors:  T Sabharwal; F G Irani; A Adam
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Jan-Feb       Impact factor: 2.740

2.  Malignant gastroduodenal obstruction: palliation with self-expanding metallic stents.

Authors:  Bertrand Bessoud; Thierry de Baere; Alban Denys; Viseth Kuoch; Michel Ducreux; Sophie Precetti; Alain Roche; Yves Menu
Journal:  J Vasc Interv Radiol       Date:  2005-02       Impact factor: 3.464

3.  Endoscopic self-expandable metallic stent placement in malignant pyloric or duodenal obstruction: does chemotherapy affect stent patency?

Authors:  Byung Hyo Cha; Sang Hyub Lee; Jang Eun Kim; Ji Youn Yoo; Young Soo Park; Jin-Wook Kim; Sook-Hyang Jeong; Nayoung Kim; Dong Ho Lee; Jin-Hyeok Hwang
Journal:  Asia Pac J Clin Oncol       Date:  2012-10-11       Impact factor: 2.601

4.  Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

Authors:  Minoru Tada; Yousuke Nakai; Takashi Sasaki; Tsuyoshi Hamada; Rie Nagano; Dai Mohri; Koji Miyabayashi; Keisuke Yamamoto; Hirofumi Kogure; Kazumichi Kawakubo; Yukiko Ito; Natsuyo Yamamoto; Naoki Sasahira; Kenji Hirano; Hideaki Ijichi; Keishuke Tateishi; Hiroyuki Isayama; Masao Omata; Kazuhiko Koike
Journal:  World J Clin Oncol       Date:  2011-03-10

5.  Impact of S-1 on the survival of patients with advanced pancreatic cancer.

Authors:  Yousuke Nakai; Hiroyuki Isayama; Takashi Sasaki; Naoki Sasahira; Yukiko Ito; Hirofumi Kogure; Osamu Togawa; Saburo Matsubara; Toshihiko Arizumi; Hiroshi Yagioka; Yoko Yashima; Kazumichi Kawakubo; Suguru Mizuno; Keisuke Yamamoto; Kenji Hirano; Takeshi Tsujino; Hideaki Ijichi; Keisuke Tateishi; Nobuo Toda; Minoru Tada; Masao Omata; Kazuhiko Koike
Journal:  Pancreas       Date:  2010-10       Impact factor: 3.327

6.  Self-expandable metallic stent placement for palliation in gastric outlet obstructions caused by gastric cancer: a comparison with surgical gastrojejunostomy.

Authors:  Iruru Maetani; Sotaro Akatsuka; Masaki Ikeda; Tomoko Tada; Takeo Ukita; Yoichi Nakamura; Jiro Nagao; Yoshihiro Sakai
Journal:  J Gastroenterol       Date:  2005-10       Impact factor: 7.527

7.  Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer.

Authors:  Takashi Sasaki; Hiroyuki Isayama; Yousuke Nakai; Yukiko Ito; Hirofumi Kogure; Osamu Togawa; Nobuo Toda; Ichiro Yasuda; Osamu Hasebe; Iruru Maetani; Naoki Sasahira; Kenji Hirano; Takeshi Tsujino; Minoru Tada; Masao Omata
Journal:  Cancer Chemother Pharmacol       Date:  2009-08-26       Impact factor: 3.333

8.  Improved oral intake after palliative duodenal stenting for malignant obstruction: a prospective multicenter clinical trial.

Authors:  Michael Piesman; Richard A Kozarek; John J Brandabur; Douglas K Pleskow; Ram Chuttani; Viktor E Eysselein; William B Silverman; John J Vargo; Irving Waxman; Marc F Catalano; Todd H Baron; Willis G Parsons; Adam Slivka; David L Carr-Locke
Journal:  Am J Gastroenterol       Date:  2009-08-25       Impact factor: 10.864

9.  First data on the palliative treatment of patients with malignant gastric outlet obstruction using the WallFlex enteral stent: a retrospective multicenter study.

Authors:  J van Hooft; M Mutignani; A Repici; H Messmann; H Neuhaus; P Fockens
Journal:  Endoscopy       Date:  2007-05       Impact factor: 10.093

10.  Clinical outcomes of self-expandable metal stent and prognostic factors for stent patency in gastric outlet obstruction caused by gastric cancer.

Authors:  Yu Kyung Cho; Sang Woo Kim; Won Haeng Hur; Kwan Woo Nam; Jae Hyuck Chang; Jae Myung Park; In Seok Lee; Myung-Gyu Choi; In-Sik Chung
Journal:  Dig Dis Sci       Date:  2009-03-31       Impact factor: 3.199

View more
  1 in total

1.  Preoperative geriatric nutritional risk index is a useful prognostic indicator in elderly patients with gastric cancer.

Authors:  Noriyuki Hirahara; Takeshi Matsubara; Yusuke Fujii; Shunsuke Kaji; Ryoji Hyakudomi; Tetsu Yamamoto; Yuki Uchida; Yoshiko Miyazaki; Kazunari Ishitobi; Yasunari Kawabata; Yoshitsugu Tajima
Journal:  Oncotarget       Date:  2020-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.